Summary Slide.png (97.2 kB)
Download fileExtrapolation of Survival Benefits in Patients With Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
media
posted on 2020-05-27, 16:17 authored by Benjamin Li, Jose Alvir, Michelle StewartThe above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.